ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Advanced Fallopian Tube Carcinoma|Advanced Ovarian Carcinoma|Advanced Primary Peritoneal Carcinoma|Anatomic Stage IV Breast Cancer AJCC v8|Metastatic Triple-Negative Breast Carcinoma|Stage III Fallopian Tube Cancer AJCC v8|Stage III Ovarian Cancer AJCC v8|Stage III Primary Peritoneal Cancer AJCC v8|Stage IV Fallopian Tube Cancer AJCC v8|Stage IV Ovarian Cancer AJCC v8|Stage IV Primary Peritoneal Cancer AJCC v8
Interventions: DRUG: Wee1 Inhibitor ZN-c3
Sponsor: OHSU Knight Cancer Institute
Collaborators: Oregon Health and Science University